DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Acular (Ketorolac Tromethamine Ophthalmic) - News


News related to Acular (Ketorolac Ophthalmic) and/or conditions it is approved for

Aflibercept in macular oedema after BRVO: No hint of added benefit
Source: Eye Health / Blindness News From Medical News Today [2015.06.24]
Dossier contained no suitable data, manufacturer itself claimed no added benefitSince February 2015, aflibercept (trade name Eylea) has been available also for patients with impaired vision due...

Patient-Reported Vision Improves After Ocriplasmin for Vitreomacular Adhesion
Source: Medscape Ophthalmology Headlines [2015.06.22]
Patients report meaningful improvements in vision after ocriplasmin treatment for vitreomacular adhesion (VMA), according to a pair of multicenter trials.
Reuters Health Information

Scripps team lays 'spectacular' foundations for HIV vaccine
Source: HIV / AIDS News From Medical News Today [2015.06.19]
Researchers at The Scripps Institute report preliminary success in designing a component for a potential HIV vaccine based on immunogens, rather than a deactivated virus.

NICE recommends EYLEA for visual impairment due to diabetic macular oedema (DMO)
Source: Eye Health / Blindness News From Medical News Today [2015.06.02]
The National Institute for Health and Care Excellence (NICE) draft Final Appraisal Determination (FAD) recommends EYLEA for the treatment of patients with visual impairment due to diabetic macular...

Macular Degeneration
Source: MedicineNet Cataracts Specialty [2015.05.07]
Title: Macular Degeneration
Category: Diseases and Conditions
Created: 7/23/1999 12:00:00 AM
Last Editorial Review: 5/7/2015 12:00:00 AM

Jetrea Gets FDA Nod for Macular Adhesion
Source: MedPage Today Product Alert [2012.10.19]
WASHINGTON -- The FDA has approved ocriplasmin (Jetrea) as the first nonsurgical treatment for symptomatic vitreomacular adhesion.

'Miniature Telescope' for Eye Approved for Macular Degeneration
Source: MedicineNet Macular Degeneration (Age-Related Type) Specialty [2010.07.07]
Title: 'Miniature Telescope' for Eye Approved for Macular Degeneration
Category: Health News
Created: 7/6/2010 2:10:00 PM
Last Editorial Review: 7/7/2010

Ruboxistaurin (RBX) may reduce risk of vision loss in diabetics
Source: The Doctors Lounge - Endocrinology and Diabetes
Phase III trial demonstrates ruboxistaurin (RBX) may reduce the risk of vision loss especially in diabetic macular edema.

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015